Martin P. Sutter - 02 Jun 2025 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: Director, 10%+ Owner
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 02 Jun 2025
Transactions value $: $0
Form type: 4
Filing time: 04 Jun 2025, 21:30:50 UTC
Previous filing: 13 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SUTTER MARTIN P	Director, 10%+ Owner	4721 EMPEROR BOULEVARD, SUITE 100, DURHAM	/s/ Anthony D'Adamio, Attorney-in-Fact	04 Jun 2025	0001017832

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BVS	Class A Common Stock	Options Exercise	$0	+26.5K	+45.1%	$0.00	85.2K	02 Jun 2025	Direct
holding	BVS	Class A Common Stock						13M	02 Jun 2025	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Restricted Stock Units	Options Exercise	$0	-26.5K	-100%	$0.00	0	02 Jun 2025	Class A Common Stock	26.5K		Direct	F2, F3
transaction	BVS	Restricted Stock Units	Award	$0	+32.3K		$0.00	32.3K	03 Jun 2025	Class A Common Stock	32.3K		Direct	F2, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 12,096,702 shares of Class A Common Stock held by EW Healthcare Partners Acquisition Fund, L.P. ("Essex Stockholder") and 924,622 shares of Class A Common Stock held by White Pine Medical, LLC ("White Pine"). EW Healthcare Partners Acquisition Fund UGP, LLC ("General Partner") is the general partner of EW Healthcare Partners Acquisition Fund GP, L.P., which is the general partner of Essex Stockholder, which is the managing member of White Pine. Messrs. Sutter, Vainio, Eastman, and Barry (collectively, the "Managers") are the managers of the General Partner. The Managers disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F3	The RSUs vested on June 2, 2025.
F4	The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.